Cargando…
154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis
BACKGROUND: Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development as a potential treatment for allergic rhinitis. The objective of this study was to determine the long-term safety and efficacy of CIC-HFA compared to placebo in subjects with perennial allergic rhinitis (PA...
Autores principales: | Berger, William, Mohar, Dale, Raphael, Gordon, LaForce, Craig, Huang, Holly, Desai, Shailesh, Bode, Frederick, Karafilidis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512737/ http://dx.doi.org/10.1097/01.WOX.0000411911.97281.2a |
Ejemplares similares
-
146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
por: Mohar, Dale, et al.
Publicado: (2012) -
247 Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients With Perennial Allergic Rhinitis Treated with Fix Combination of Montelukast Plus Desloratadine
por: Cingi, Cemal, et al.
Publicado: (2012) -
29 Allergic Rhinitis to Ragweed Pollen
por: Bocsan, Ioana Corina, et al.
Publicado: (2012) -
112 Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children
por: Oropeza, Said Arablin, et al.
Publicado: (2012) -
241 Nasal Cytology is Important in the Classification of Patients with Allergic and Non-Allergic Rhinitis
por: Mion, Olavo, et al.
Publicado: (2012)